| P50 | author | Mathew T Martin-Iverson | Q59683370 |
| P2093 | author name string | Richard J Beninger | |
| | Angela E McLelland | |
| P2860 | cites work | Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding | Q28297725 |
| | Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat | Q29619517 |
| | H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. | Q33964839 |
| | Additional evidence of the abuse potential of quetiapine | Q34005887 |
| | The role of antihistaminic effects in the misuse of quetiapine: a case report and review of the literature | Q34020085 |
| | Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity | Q34048782 |
| | Quetiapine: efficacy and tolerability in schizophrenia | Q34392471 |
| | Flunitrazepam: an evaluation of use, abuse and toxicity. | Q34416413 |
| | Cocaine, reward, movement and monoamine transporters | Q34502175 |
| | Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine. | Q35026544 |
| | Pharmacologic management of anxiety disorders in children and adolescents | Q35542974 |
| | Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders. | Q36205791 |
| | A preclinical and clinical rationale for quetiapine in mood syndromes | Q36847279 |
| | Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade | Q36902047 |
| | Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients | Q37727085 |
| | N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity | Q40039619 |
| | Prediction of catalepsies induced by amiodarone, aprindine and procaine: similarity in conformation of diethylaminoethyl side chain. | Q42538408 |
| | The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine | Q42595162 |
| | Quetiapine anxiolytic-like effect in the Vogel conflict test is serotonin dependent | Q42923008 |
| | Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine | Q42982683 |
| | Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine | Q43153771 |
| | Quetiapine blocks cocaine-induced enhancement of brain stimulation reward | Q43234977 |
| | In vivo 5-HT2A receptor blockade by quetiapine: an R91150 single photon emission tomography study | Q43712186 |
| | Intranasal quetiapine abuse | Q43733561 |
| | Quetiapine addiction? | Q44118337 |
| | Treatment with the atypical antipsychotic, olanzapine, prevents the expression of amphetamine-induced place conditioning in the rat. | Q44292636 |
| | Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine | Q44843746 |
| | Quetiapine ameliorates anxiety-like behavior and cognitive impairments in stressed rats: implications for the treatment of posttraumatic stress disorder. | Q45963533 |
| | Chronic administration of quetiapine alleviates the anxiety-like behavioural changes induced by a neurotoxic regimen of dl-amphetamine in rats | Q46442773 |
| | Addictive potential of quetiapine | Q46507544 |
| | Quetiapine: another drug with potential for misuse? A case report | Q46724441 |
| | Lesions of the dorsal lateral septum do not affect neophagia in the novelty induced suppression of feeding paradigm but reduce defensive behaviours in the elevated plus maze and shock probe burying tests | Q48151133 |
| | The tuberomammillary nucleus region as a reinforcement inhibiting substrate: facilitation of ipsihypothalamic self-stimulation by unilateral ibotenic acid lesions | Q48267736 |
| | Increased levels of extracellular dopamine in neostriatum and nucleus accumbens after histamine H1 receptor blockade | Q48344452 |
| | Seroquel: electrophysiological profile of a potential atypical antipsychotic | Q48389494 |
| | Seroquel: biochemical profile of a potential atypical antipsychotic | Q48389501 |
| | Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. | Q48437323 |
| | Dopamine D1-like receptors and reward-related incentive learning | Q48474345 |
| | Place preference conditioning with methylphenidate and nomifensine | Q48496187 |
| | Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens | Q48826526 |
| | Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions | Q48859197 |
| | Dopaminergic substrates of amphetamine-induced place preference conditioning | Q48859202 |
| | Radioreceptor binding profile of the atypical antipsychotic olanzapine | Q49130929 |
| | Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat. | Q49143985 |
| | The effects of selective dopamine D1 or D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats | Q50142844 |
| | Clozapine attenuates cocaine conditioned place preference. | Q51645843 |
| | The effects of haloperidol on amphetamine- and methylphenidate-induced conditioned place preferences and locomotor activity. | Q52263847 |
| | Quetiapine Addiction? | Q56817120 |
| | Human norepinephrine transporter kinetics using rotating disk electrode voltammetry | Q71507054 |
| | Amphetamine reverses or blocks the operation of the human noradrenaline transporter depending on its concentration: superfusion studies on transfected cells | Q77292449 |
| | Intravenous quetiapine-cocaine use ("Q-ball") | Q79485993 |
| | The growing abuse of commonly prescribed psychiatric medications | Q81596686 |
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | elevated plus maze | Q5359685 |
| P304 | page(s) | 4349-4359 | |
| P577 | publication date | 2014-05-07 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | The effect of quetiapine (Seroquel™) on conditioned place preference and elevated plus maze tests in rats when administered alone and in combination with (+)-amphetamine | |
| P478 | volume | 231 | |